14.09USD+0.39%Mkt Cap: 3.07B USDP/E: —Last update: 2026-06-01
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.07B USD
Enterprise Value2.08B USD
Revenue (TTM)10.68M USD
Gross Profit-245.58M USD
Net Income (TTM)-276.48M USD
Revenue/Share0.0610 USD
Last Price14.09 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees193
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.41
PEG—
EV/EBITDA-7.08
EV/Revenue194.86
P/S286.82
P/B4.31
EPS (TTM)-1.56
EPS (Forward)-1.67
52W Range
2.92078% of range17.32
52W High17.32 USD
52W Low2.920 USD
Profitability
Gross Margin0.00%
Oper. Margin-2619.67%
EBITDA Margin0.00%
Profit Margin-1800.58%
ROE-48.76%
ROA-44.50%
Growth
Revenue Growth-60.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-235.46M USD
CapEx (TTM)410.00K USD
FCF Margin-1135.08%
FCF Yield-3.95%
Net Debt-610.50M USD
Net Debt/EBITDA2.08
Balance Sheet
Debt/Equity0.06
Current Ratio22.13
Quick Ratio21.58
Book Value/Sh3.261 USD
Cash/Share3.351 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)24.25 USD
Target Range18.00 USD – 32.00 USD
# Analysts12
Ownership
Shares Out.217.94M
Float136.02M
Insiders1.39%
Institutions86.97%
Short Interest
Short Ratio9.5d
Short % Float17.94%
Short % Out.15.05%
Shares Short28.82M
Short (prev mo.)27.00M
Technical
SMA 5013.10 (+7.5%)
SMA 2008.533 (+65.1%)
Beta1.75
S&P 52W Chg27.70%
Avg Vol (30d)3.68M
Avg Vol (10d)5.78M
Technical Indicators
RSI (14)57.1
MACD0.1966
MACD Signal0.0440
MACD Hist.+0.1526
BB Upper14.45 USD
BB Middle13.10 USD
BB Lower11.74 USD
BB Width20.67%
ATR (14)0.9865 USD
Vol Ratio (20d)0.33x